NEWS & EVENTS
PRESS RELEASES 2007
ELUSYS TO PRESENT AT BIO INVESTORFORUM 2007
Pine Brook, NJ – Sept. 25, 2007 – Elusys Therapeutics, Inc. (Elusys), a privately held biopharmaceutical company developing antibody-based therapies for the treatment of life- threatening infectious diseases, today announced that Elizabeth Posillico, Ph.D., President and Chief Executive Officer, will present at BIO InvestorForum 2007 at the Palace Hotel in San Francisco, CA, from October 9-11, 2007. Dr. Posillico will present on Wednesday, October 10 at 10:45 AM. She will be available for one-on-one meetings during the conference.
BIO InvestorForum 2007 will feature corporate presentations and dynamic panel discussions on the opportunities and challenges facing the industry. The program includes public and venture-stage company presentations, expert-led workshops on the latest market and investment opportunities with an emphasis on drug and technology development. There will also be one-on-one investor meetings and breakout sessions between presenting company executives and investors. In attendance will be institutional investors, hedge fund managers, venture and private equity investors, as well as research analysts and bankers representing leading banking institutions. For more information please visit
http://investorforum.bio.org/opencms/bif/2007/index.jsp
About Elusys
Elusys is a privately held biopharmaceutical company focused on the development of antibody-based therapies for the treatment of life-threatening infectious disease. Current venture investors include Essex Woodlands Health Ventures LLC, Invesco Private Capital, Crescendo Ventures, MedImmune Ventures and Pfizer. For more information please visit www.elusys.com.